Table 4.
Correlation between histological type and clinical features
| Characteristics | PTC (n = 1145) | PTMC (n = 1295) | Other (n = 50) | χ 2/F | P |
|---|---|---|---|---|---|
| Gender | |||||
| Male (n = 606) | 308 (26.9%) | 283 (21.9%) | 15 (30%) | 9.292 | 0.01 |
| Female (n = 1884) | 837 (73.1%) | 1012 (78.1%) | 35 (70%) | ||
| Age | |||||
| Average | 42.2 ± 11.89 | 44.2 ± 10.22 | 47.0 ± 12.93 | 14.1 | < 0.001 |
| Median | 42 (5–80) | 45 (13–76) | 47 (8–71) | ||
| Weight | 64.8 ± 12.32 | 63.6 ± 10.35 | 62.9 ± 9.80 | 3.794 | 0.023 |
| Blood type | |||||
| A (n = 718) | 312 (27.2%) | 397 (30.7%) | 9 (18.0%) | 19.793 | 0.003 |
| B (n = 754) | 325 (28.4%) | 408 (31.5%) | 21 (42.0%) | ||
| AB (n = 382) | 184 (16.1%) | 186 (14.4%) | 12 (24.0%) | ||
| O (n = 636) | 324 (28.3%) | 304 (23.5%) | 8 (16.0%) | ||
| Lesion | |||||
| Unilateral (n = 1473) | 683 (59.7%) | 752 (58.1%) | 38 (76.0%) | 6.62 | 0.037 |
| Bilateral (n = 1017) | 462 (40.3%) | 543 (41.9%) | 12 (24.0%) | ||
| Focal | |||||
| Unifocal (n = 1370) | 714 (62.4%) | 625 (48.3%) | 31 (62.0%) | 20.596 | <0.001 |
| Multifocal (n = 1120) | 488 (42.6%) | 670 (51.7%) | 19 (38.0%) | ||
| LN metastasis | |||||
| Yes (n = 1174) | 826 (72.1%) | 984 (76.0%) | 12 (24.0%) | 67.426 | < 0.001 |
| No (n = 1316) | 319 (27.9%) | 311 (24.0%) | 38 (76.0%) | ||
|
BRAF mutation (n = 1708) |
|||||
| Yes (n = 1444) | 644/761 (84.6%) | 792/928 (85.3%) | 8/19 (42.1%) | 36.646 | < 0.001 |
| No (n = 264) | 117/761 (15.4%) | 136/928 (14.7%) | 11/19 (57.9%) | ||
| Recurrence | |||||
| Yes | 90 (7.9%) | 94 (7.3%) | 4 (8.0%) | 0.330 | 0.848 |
| No | 1055 (92.1%) | 1201 (92.7%) | 46 (92.0%) |
LN, lymph node.